Interneuron regulatory update

The FDA's Endocrinologic and Metabolic Advisory Committee (EMAC) will meet Sept. 28 to consider IPIC's dexfenfluramine to treat obesity. The Lexington, Mass., company filed its NDA in May 1993. ...